Apr 11
|
Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More
|
Apr 11
|
AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use
|
Apr 10
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
Apr 10
|
Trending tickers: TSMC, Trump Media, US Steel, Novo Nordisk and Tesco
|
Apr 9
|
AstraZeneca (LSE:AZN) Gains EU Approval For Breast Cancer Treatment DATROWAY
|
Apr 9
|
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
|
Apr 9
|
Trump Says Pharmaceutical Tariffs Coming ‘Very Shortly’
|
Apr 9
|
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca
|
Apr 9
|
3 No-Brainer Growth Stocks to Buy for Less Than $100
|
Apr 8
|
Astrazeneca (AZN) Stock Moves -1.35%: What You Should Know
|
Apr 8
|
AstraZeneca’s camizestrant gains momentum, but questions remain as first-line therapy
|
Apr 7
|
AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs
|
Apr 7
|
EC approves AstraZeneca’s Imfinzi combo for NSCLC
|
Mar 14
|
AstraZeneca Stock Scores RS Rating Upgrade
|
Mar 14
|
INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participants
|
Mar 14
|
AstraZeneca director says AI must be a “thought partner” in drug discovery
|
Mar 14
|
AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer
|
Mar 13
|
AstraZeneca Stock Nears Buy Point After Long Run In Declining Market
|
Mar 13
|
Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?
|
Mar 12
|
Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
|